Lv44
584 积分 2024-02-22 加入
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
1天前
已完结
Site‐specific Quadruple‐Functionalised Antibodies
18天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
18天前
已完结
BINDTI: A bi-directional Intention network for drug-target interaction identification based on attention mechanisms
27天前
已完结
AI-powered therapeutic target discovery
29天前
已完结
How many rare diseases are there?
29天前
已完结
Rare tumors: a blue ocean of investigation
29天前
已完结
Targeted therapy for rare lung cancers: Status, challenges, and prospects
1个月前
已完结
One-Pot Assembly of Dual-Site-Specific Antibody–Drug Conjugates via Glycan Remodeling and Affinity-Directed Traceless Conjugation
1个月前
已完结
One-Pot Assembly of Dual-Site-Specific Antibody–Drug Conjugates via Glycan Remodeling and Affinity-Directed Traceless Conjugation
1个月前
已完结
皖公网安备34019202002308
